Literature DB >> 29540575

Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.

Valentin Blanchard1,2, Stéphane Ramin-Mangata2, Stéphanie Billon-Crossouard1,3, Audrey Aguesse1,3, Manon Durand1,4, Kevin Chemello2, Brice Nativel2, Laurent Flet5, Maud Chétiveaux1, David Jacobi4,6, Jean-Marie Bard1,7, Khadija Ouguerram1,3, Gilles Lambert2, Michel Krempf1,3,6, Mikaël Croyal8,3.   

Abstract

Human apoE exhibits three major isoforms (apoE2, apoE3, and apoE4) corresponding to polymorphism in the APOE gene. Total plasma apoE concentrations are closely related to these isoforms, but the underlying mechanisms are unknown. We aimed to describe the kinetics of apoE individual isoforms to explore the mechanisms for variable total apoE plasma concentrations. We used LC-MS/MS to discriminate between isoforms by identifying specific peptide sequences in subjects (three E2/E3, three E3/E3, and three E3/E4 phenotypes) who received a primed constant infusion of 2H3-leucine for 14 h. apoE concentrations and leucine enrichments were measured hourly in plasma. Concentrations of apoE2 were higher than apoE3, and concentrations of apoE4 were lower than apoE3. There was no difference between apoE3 and apoE4 catabolic rates and between apoE2 and apoE3 production rates (PRs), but apoE2 catabolic rates and apoE4 PRs were lower. The mechanisms leading to the difference in total plasma apoE concentrations are therefore related to contrasted kinetics of the isoforms. Production or catabolic rates are differently affected according to the specific isoforms. On these grounds, studies on the regulation of the involved biochemical pathways and the impact of pathological environments are now warranted.
Copyright © 2018 Blanchard et al.

Entities:  

Keywords:  lipoprotein/kinetics; lipoprotein/metabolism; liquid chromatography; peptide; stable isotope tracers; tandem mass spectrometry

Mesh:

Substances:

Year:  2018        PMID: 29540575      PMCID: PMC5928431          DOI: 10.1194/jlr.P083576

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  38 in total

1.  Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

Authors:  R Batal; M Tremblay; P H Barrett; H Jacques; A Fredenrich; O Mamer; J Davignon; J S Cohn
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

2.  Quantitative clinical proteomics by liquid chromatography-tandem mass spectrometry: assessing the platform.

Authors:  Andrew N Hoofnagle
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

Review 3.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.

Authors:  R W Mahley; Z S Ji
Journal:  J Lipid Res       Date:  1999-01       Impact factor: 5.922

4.  Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.

Authors:  Eduardo Martínez-Morillo; Oskar Hansson; Yuka Atagi; Guojun Bu; Lennart Minthon; Eleftherios P Diamandis; Henrietta M Nielsen
Journal:  Acta Neuropathol       Date:  2014-03-15       Impact factor: 17.088

5.  Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility.

Authors:  Andrew J Percy; Andrew G Chambers; Juncong Yang; Darryl B Hardie; Christoph H Borchers
Journal:  Biochim Biophys Acta       Date:  2013-06-25

6.  Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins.

Authors:  A Steinmetz; C Jakobs; S Motzny; H Kaffarnik
Journal:  Arteriosclerosis       Date:  1989 May-Jun

7.  Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic Patients.

Authors:  Mikaël Croyal; Khadija Ouguerram; Maxime Passard; Véronique Ferchaud-Roucher; Maud Chétiveaux; Stéphanie Billon-Crossouard; Anne-Charlotte de Gouville; Gilles Lambert; Michel Krempf; Estelle Nobécourt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-09       Impact factor: 8.311

8.  Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry.

Authors:  Kristin R Wildsmith; Bomie Han; Randall J Bateman
Journal:  Anal Biochem       Date:  2009-08-03       Impact factor: 3.365

9.  Quantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC-MS/MS.

Authors:  Uta Ceglarek; Julia Dittrich; Susen Becker; Frank Baumann; Linda Kortz; Joachim Thiery
Journal:  Proteomics Clin Appl       Date:  2013-10-31       Impact factor: 3.494

10.  In vivo human apolipoprotein E isoform fractional turnover rates in the CNS.

Authors:  Kristin R Wildsmith; Jacob M Basak; Bruce W Patterson; Yuriy Pyatkivskyy; Jungsu Kim; Kevin E Yarasheski; Jennifer X Wang; Kwasi G Mawuenyega; Hong Jiang; Maia Parsadanian; Hyejin Yoon; Tom Kasten; Wendy C Sigurdson; Chengjie Xiong; Alison Goate; David M Holtzman; Randall J Bateman
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

View more
  11 in total

1.  A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

Authors:  Valentin Blanchard; Damien Garçon; Catherine Jaunet; Kevin Chemello; Stéphanie Billon-Crossouard; Audrey Aguesse; Aya Garfa; Gilles Famchon; Amada Torres; Cédric Le May; Matthieu Pichelin; Edith Bigot-Corbel; Gilles Lambert; Bertrand Cariou; Samy Hadjadj; Michel Krempf; Kalyane Bach-Ngohou; Mikaël Croyal
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

2.  Putting Humpty Dumpty Back Together Again: What Does Protein Quantification Mean in Bottom-Up Proteomics?

Authors:  Deanna L Plubell; Lukas Käll; Bobbie-Jo Webb-Robertson; Lisa M Bramer; Ashley Ives; Neil L Kelleher; Lloyd M Smith; Thomas J Montine; Christine C Wu; Michael J MacCoss
Journal:  J Proteome Res       Date:  2022-02-27       Impact factor: 4.466

3.  Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment.

Authors:  Ilijana Begcevic Brkovic; Benedikt Zöhrer; Markus Scholz; Madlen Reinicke; Julia Dittrich; Surab Kamalsada; Ronny Baber; Frank Beutner; Andrej Teren; Christoph Engel; Kerstin Wirkner; Holger Thiele; Markus Löffler; Steffi G Riedel-Heller; Uta Ceglarek
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

Review 4.  APOE Alleles and Diet in Brain Aging and Alzheimer's Disease.

Authors:  Hussein N Yassine; Caleb E Finch
Journal:  Front Aging Neurosci       Date:  2020-06-10       Impact factor: 5.750

5.  Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan.

Authors:  Diego Iacono; Gloria C Feltis
Journal:  Aging (Albany NY)       Date:  2019-01-24       Impact factor: 5.682

6.  Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid.

Authors:  Yueming Hu; Cristiana Meuret; Scholastica Go; Hussein N Yassine; Dobrin Nedelkov
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

7.  Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes.

Authors:  Mikaël Croyal; Matthieu Wargny; Kevin Chemello; Chloé Chevalier; Valentin Blanchard; Edith Bigot-Corbel; Gilles Lambert; Cédric Le May; Samy Hadjadj; Bertrand Cariou
Journal:  Cardiovasc Diabetol       Date:  2022-02-07       Impact factor: 9.951

Review 8.  Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids.

Authors:  Magdalena Korecka; Leslie M Shaw
Journal:  J Neurochem       Date:  2021-08-25       Impact factor: 5.546

Review 9.  Lipoprotein(a) Lowering-From Lipoprotein Apheresis to Antisense Oligonucleotide Approach.

Authors:  Maria Francesca Greco; Cesare R Sirtori; Alberto Corsini; Marat Ezhov; Tiziana Sampietro; Massimiliano Ruscica
Journal:  J Clin Med       Date:  2020-07-03       Impact factor: 4.964

Review 10.  Proteomics Landscape of Alzheimer's Disease.

Authors:  Ankit P Jain; Gajanan Sathe
Journal:  Proteomes       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.